Specialized expertise, engaged by scope
Integral BioStrategy is partner-led by Ivan A. Valdez, PhD and Alfred Atallah, JD. When a scoped question calls for complementary expertise, specialized advisors may contribute perspective across clinical strategy, commercialization, neuroscience, cancer biology, and biomedical science.
Integral BioStrategy's About page now combines leadership, focused advisory bench, and operating-model information.
Clinical psychologist and digital health leader with experience in care-model design, behavioral health innovation, program development, patient engagement, outcomes frameworks, and behavior-change strategy.
Penn-trained neuroscientist, Harvard Medical School / Boston Children's research fellow, and Dean of Health Professions with experience in biomedical research, healthcare education, workforce training, and translational program leadership.
Harvard-trained cancer biology scientist with experience in biomedical research, STEM education, mentorship, program development, and scientific training. She currently serves as Associate Dean at Yale School of Medicine / Office of Collaborative Excellence.
Advisors may contribute when their expertise is relevant to a scoped engagement. Advisor participation does not imply endorsement by or representation of any current employer or institution. Standard Integral BioStrategy engagements remain scientific and strategic advisory unless additional expertise is separately scoped in writing.
A question that calls for complementary expertise?
For confidential biotech, spinout, investor, or strategic diligence inquiries, start with a brief scoping conversation.
Request a confidential scoping callPrefer email? [email protected]